<DOC>
	<DOCNO>NCT00177788</DOCNO>
	<brief_summary>The study aim determine voriconazole prevents invasive fungal infection liver transplant recipient . Endpoints would : occurrence invasive fungal infection fungal colonization . Two group compare : patient receive voriconazole prophylaxis historical control receive prophylaxis .</brief_summary>
	<brief_title>Voriconazole Prophylaxis Liver Transplant Recipients</brief_title>
	<detailed_description>The following variable follow : time location positive culture , underlie disease severity illness , voriconazole usage prophylactically , physical exam finding , laboratory radiographical data , antimicrobial usage , microbiological data resistance pattern , choice antifungal drug organism identify , suspect source infection , microbiological outcome , laboratory result , demographic information , medication , clinical outcome , gender , weight , ethnicity , past medical history .</detailed_description>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Fungemia</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Patients receive liver transplant University Pittsburgh Medical Center ( UPMC ) January 1 , 2001 June 30 , 2005 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>liver transplant</keyword>
	<keyword>voriconazole prophylaxis</keyword>
	<keyword>liver transplantation</keyword>
	<keyword>voriconazole</keyword>
</DOC>